XTalks

NOVEMBER 15, 2022

In Lilly’s case, the fake account claimed the company was giving out free insulin. A fraudulent Eli Lilly account with the username @EliLillyandCo tweeted a message on November 10 that said: “We are excited to announce insulin is free now.”. On average, it is estimated that insulin costs about $98.70 percent, or by $16.08

Insulin 97

Insulin Sales Branding Production 97

XTalks

JULY 3, 2023

The treatment is derived from deceased donor pancreatic cells and is indicated for patients who are unable to achieve average blood glucose levels (glycated hemoglobin) with daily insulin injections or with continuous infusion through a pump because of repeated episodes of severe hypoglycemia (low blood sugar).

Insulin 98

Insulin Gene Therapy Gene Regulation 98

XTalks

SEPTEMBER 14, 2022

Ayesha also talked about Medtronic’s new partnership with former Disney star Jennifer Stone on a new ad campaign for its diabetes tech, including the smart insulin injector InPen. Subscribe to the Xtalks Life Science Podcast to never miss a new episode. Hear more about the rare, fatal disease and the new drug approval for it.

Life Science 90

Life Science FDA Approval Insulin Drugs 90

XTalks

AUGUST 9, 2023

In this episode, Ayesha talked about the FDA clearance of the world’s smallest insulin pump from Tandem Diabetes Care. The insulin pump, called the Tandem Mobi, features an automated insulin delivery system with options for manual delivery as well. Subscribe to the Xtalks Life Science Podcast to never miss a new episode.

Insulin 52

Insulin Life Science 52

XTalks

NOVEMBER 16, 2022

Ayesha also talked about Eli Lilly falling victim to a fake Twitter account that tweeted the company was offering free insulin. Lilly clarified the fake message, but the tweet has re-ignited debate about the cost of insulin in the US. Fraudulent Eli Lilly Twitter Account Announces Free Insulin.

Insulin 52

Insulin Life Science Marketing Drugs 52

XTalks

OCTOBER 13, 2021

The editorial team also discussed Medtronic’s expanded recalls of the remote controllers for certain models of its MiniMed insulin pumps over cybersecurity concerns, as well as its 600 series insulin pumps due to a faulty retainer ring. Medtronic Expands Two Insulin Pump Recalls, Including One Over Cybersecurity Concerns.

Insulin 45

Insulin Life Science Vaccine Vaccination 45

XTalks

MARCH 22, 2023

Tidepool recently received US Food and Drug Administration (FDA) clearance of Tidepool Loop, an automated insulin dosing app meant for the management of type 1 diabetes in patients who are six years of age and older. Subscribe to the Xtalks Life Science Podcast to never miss a new episode.

Life Science 52

Life Science Insulin Drugs 52

XTalks

JUNE 14, 2024

Ontario, Canada’s largest province by population, is stepping up its commitment to the life sciences sector with an investment of $40 million. The $40 million will come from the Venture Ontario Fund, which is dedicated to helping Ontario life sciences companies and biomanufacturers innovate, grow and compete in global markets.

Life Science 52

Life Science Insulin Research Manufacturing 52

XTalks

AUGUST 30, 2023

million insulin pricing settlement. The states join six others who have been fighting Eli Lilly in court since 2017, claiming that the company hiked prices of its insulin product Humalog. Hear more about the insulin pricing controversy in this episode. The states say the $13.5 The states say the $13.5

Insulin 52

Insulin FDA Approval Life Science Production 52

XTalks

NOVEMBER 21, 2024

These gut hormones are released in response to nutrient intake and play a crucial role in the incretin effect, which enhances insulin secretion. It’s the first and only approved dual agonist targeting both the GIP and GLP-1 receptors. Researchers monitored a range of health metrics, including fasting glucose, HbA1c levels and weight changes.

Sales 105

Sales Insulin Drugs Trials 105

XTalks

JULY 27, 2022

Toleikis spoke about the latest clinical trial data for the medical device, and also about the company’s new partnership with Evotec to integrate its insulin-producing cells in the Cell Pouch System. Subscribe to the Xtalks Life Science Podcast to never miss a new episode.

Life Science 52

Life Science Insulin Clinical Trials Clinical Trials 52

XTalks

AUGUST 13, 2024

Abbott and Medtronic have struck a global partnership to make diabetes management easier for people who need regular insulin injections. Abbott’s CGM sensors will work with Medtronic’s AID algorithms to automatically adjust insulin levels based on real-time blood sugar readings. billion by 2033.

Insulin 52

Insulin FDA Approval Marketing Development 52

Pharmaceutical Technology

FEBRUARY 16, 2023

Despite such a broad range of pathologies, the commonality between them is the insulin response. dietary restriction) of the evolutionarily conserved insulin signalling pathway. Can we extend human life? These experiments demonstrated that the linkage between ageing and insulin was conserved up the evolutionary tree.

Insulin 130

Insulin DNA Genetics Life Science 130

BioTech 365

JUNE 16, 2021

Amalgam Rx™ Receives CE Mark for Basal Insulin Titration Amalgam Rx™ Receives CE Mark for Basal Insulin Titration Insulin Titration App Meets Requirements for European Launch WILMINGTON, Del.–(BUSINESS the leader in connecting healthcare providers and life sciences … Continue reading →

Insulin 40

Insulin Life Science 40

XTalks

SEPTEMBER 13, 2022

Med tech giant Medtronic is teaming up with Disney Channel’s “Wizards of Waverly Place” actress Jennifer Stone to promote its reusable smart insulin injectable InPen. The InPen system helps patients take the correct amount of insulin at the right time. The show ran from 2007 to 2012.

Insulin 96

Insulin Nurses Life Science Production 96

XTalks

NOVEMBER 23, 2022

Subscribe to the Xtalks Life Science Podcast to never miss a new episode. Pfizer Shares Positive Phase III Data for Maternal RSV Vaccine Candidate. The weekly podcast is available for streaming every Wednesday on Spotify , Apple Music and wherever you stream your podcasts.

Life Science 52

Life Science FDA Approval Vaccine Vaccination 52

XTalks

FEBRUARY 2, 2023

The US Food and Drug Administration (FDA) has recently cleared for marketing an app called Tidepool Loop which can be used with compatible devices for automated insulin dosing (AID). The Tidepool loop app involves three integral parts: an integrated continuous glucose monitor (iCGM), a controller and an insulin pump.

Insulin 52

Insulin Marketing Life Science Development 52

XTalks

MARCH 15, 2024

The drugs include Lilly’s newly approved GLP-1 obesity drug Zepbound (tirzepatide), around a dozen of the company’s insulins and migraine drug Emgality (galcanezumab). It is estimated that more than 8 million Americans rely on insulin products to manage their diabetes.

Pharmacy 111

Pharmacy Drugs Insulin Branding 111

XTalks

DECEMBER 11, 2024

Subscribe to the Xtalks Life Science Podcast to never miss a new episode. Tune into the episode to learn about Sernovas innovative cell-based approaches for the development of type 1 diabetes treatments. The weekly podcast is available for streaming every Wednesday on Spotify , Apple Music and wherever you stream your podcasts.

Life Science 52

Life Science Clinical Trials Clinical Trials Trials 52

XTalks

SEPTEMBER 15, 2020

In addition to the vaccine, the company is also developing an investigational drug called Remygen for the regeneration of endogenous insulin production and to improve hormonal response to hypoglycemia; trials to test the treatment are currently ongoing in patients that have been living with type 1 diabetes for more than five years.

Vaccine 103

Vaccine Vaccination Insulin Trials 103

XTalks

FEBRUARY 9, 2021

While type 2 diabetes is associated with inflammation, which could potentially explain the link between a COVID-19 infection and ensuing inflammatory response, the reasons for the onset of insulin-dependent type I diabetes is a bit less clear.

Insulin 105

Insulin Immune Response Hormones Research 105

XTalks

NOVEMBER 22, 2022

Type 1 diabetes, also known as insulin-dependent or juvenile diabetes, is an autoimmune disease that occurs when the body is unable to make enough insulin due to destruction of the beta insulin-producing cells in the pancreas. In the US, it is estimated that 1.45 million people are currently living with type 1 diabetes.

Insulin 97

Insulin Drugs FDA Approval Immune Response 97

XTalks

MARCH 8, 2021

GLP-1 receptor agonists lower blood glucose levels by increasing the production of insulin. GLP-1 receptor agonists mimic the action of GLP-1, an intestinal hormone that stimulates the secretion of insulin when blood glucose levels rise. GLP-1 acts on GLP-1 receptors on insulin-producing pancreatic ? GLP-1 Receptor Agonists.

Insulin 98

Insulin Hormones Clinical Trials Clinical Trials 98

XTalks

JANUARY 16, 2023

The body becomes resistant to insulin and can no longer use glucose properly as a fuel, so glucose begins circulating in the bloodstream and may lead to problems with the circulatory, nervous and immune systems. Often, diabetes medication or insulin therapy are used as management tools.

Insulin 93

Insulin Regulation Development Drugs 93

XTalks

NOVEMBER 9, 2022

GLP-1 receptor agonists, or incretin (metabolic hormones) mimetics, are analogs of the GLP-1 peptide hormone that binds to the GLP-1 receptor to regulate blood sugar levels by boosting insulin secretion. dependent insulin secretion and suppression of glucagon release. mediated glucose?dependent

Insulin 98

Insulin Hormones FDA Approval Sales 98

XTalks

MARCH 17, 2025

Amylin, a hormone co-secreted with insulin, plays a key role in regulating appetite by enhancing leptins effects the hormone that signals fullness after eating. Petrelintide, Zealand Pharmas long-acting amylin analog, is currently in Phase II clinical development and is designed for once-weekly subcutaneous injections.

Hormones 59

Hormones Drugs Sales Insulin 59

XTalks

OCTOBER 26, 2020

Autoantibody screening involves measuring levels of islet autoantibodies (iAb) that recognize antigens found in insulin-producing pancreatic beta cells. The presence of one or more iAbs indicates pancreatic autoimmunity and is consistent with a T1D diagnosis.

Insulin 98

Insulin Packaging Packaging Doctor 98

XTalks

JANUARY 16, 2025

Linsitinib, an oral small molecule that targets the insulin-like growth factor-1 receptor (IGF-1R), is designed to address the underlying mechanisms driving thyroid eye disease. It is a complication of Graves disease, an immune system condition that causes the thyroid gland to make excess amounts of thyroid hormone.

Trials 59

Trials Clinical Trials Clinical Trials Insulin 59

Pharmaceutical Technology

DECEMBER 22, 2022

The company has partnered with life sciences-focused investors Sixth Street and Royalty Pharma with an aim to bring substantial non-dilutive, low-cost capital to boost innovation and growth. Blueprint Medicines wins the Financing award this year after securing significant financing partnerships worth up to $1.25bn. Civica JAAQ Sanofi.

Insulin 130

Insulin Production Development Genetics 130

XTalks

JUNE 3, 2021

The study , published yesterday in the Endocrine Society’s Journal of Clinical Endocrinology and Metabolism , revealed that two helpings of fruit led to higher measures of insulin sensitivity than those who ate less than half a serving. Diabetes is a growing health problem globally. Keep it Fresh.

Insulin 59

Insulin Development Research Doctor 59

XTalks

DECEMBER 14, 2022

CGMs can alert diabetics sufficiently in advance of too high or low blood glucose levels, allowing the wearer to improve the situation with insulin, for example. The CGM can be integrated with insulin delivery systems and connected to devices like Apple watches and popular health apps. Dexcom, Inc. , a cellphone) every five minutes.

Insulin 98

Insulin Marketing Branding Life Science 98

BioTech 365

JUNE 16, 2021

Amalgam Rx™ and Novo Nordisk® Plan Global Expansion Amalgam Rx™ and Novo Nordisk® Plan Global Expansion Insulin Titration App, Dose Check®, to Reach Patients Worldwide WILMINGTON, Del.–(BUSINESS the leader in connecting healthcare providers and life sciences companies … Continue reading →

Insulin 40

Insulin Life Science 40

XTalks

JULY 15, 2024

Congenital HI is a genetic disorder that causes excessive insulin production by the pancreas, which lowers plasma or blood sugar. Agonist engagement of the receptor is involved in insulin and glucose regulation, and hence has therapeutic implications for diseases like diabetes and obesity.

Drugs 52

Drugs Insulin Life Science Marketing 52

XTalks

JULY 15, 2024

Congenital HI is a genetic disorder that causes excessive insulin production by the pancreas, which lowers plasma or blood sugar. Agonist engagement of the receptor is involved in insulin and glucose regulation, and hence has therapeutic implications for diseases like diabetes and obesity.

Insulin 52

Insulin Drugs Life Science Marketing 52

Scienmag

JANUARY 22, 2021

A new mechanism that underlies insulin resistance and type 2 diabetes In a new study published in Journal of Extracellular Vesicles, Chen-Yu Zhang’s group at Nanjing University, School of Life Sciences, and Antonio Vidal-Puig’s group at University of Cambridge report that pancreatic ?

Insulin 40

Insulin Life Science 40

XTalks

FEBRUARY 8, 2024

Diabetes remains a critical global challenge, affecting millions of lives and commanding significant attention from the medical, life sciences and pharmaceutical sectors. In its 2022 financial report, Sanofi reported that sales of the long-acting insulin dropped 27.6 percent in the fourth quarter and decreased 56.7 from $289.36.

Sales 52

Sales Insulin FDA Approval Drugs 52

XTalks

FEBRUARY 8, 2021

Last year, Biocon Biologics and Mylan announced they’d be seeking interchangeable status for their long-acting insulin product Semglee , developed to be an alternative to Sanofi’s Lantus (insulin glargine). This includes information on approved indications and risk statements applicable to both the biosimilar and its reference product.

Production 78

Production Insulin Branding Generic Drugs 78